1. Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis. (1st January 2019) Authors: Leonardi, C.; Papp, K.; Strober, B.; Thaçi, D.; Warren, R.B.; Tyring, S.; Arikan, D.; Karunaratne, M.; Valdecantos, W.C. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis3. (10th October 2018) Authors: Leonardi, C.; Papp, K.; Strober, B.; Thaçi, D.; Warren, R.B.; Tyring, S.; Arikan, D.; Karunaratne, M.; Valdecantos, W.C. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of adalimumab across subgroups of patients with moderate‐to‐severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH. (22nd June 2013) Authors: Poulin, Y.; Crowley, J.J.; Langley, R.G.; Unnebrink, K.; Goldblum, O.M.; Valdecantos, W.C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 7(2014:Jul.) Page Start: 882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term safety of adalimumab in adult patients with plaque psoriasis. (1st January 2019) Authors: Leonardi, C.; Papp, K.; Strober, B.; Thaçi, D.; Warren, R.B.; Tyring, S.; Arikan, D.; Karunaratne, M.; Valdecantos, W.C. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term safety of adalimumab in adult patients with plaque psoriasis. (2nd January 2019) Authors: Leonardi, C.; Papp, K.; Strober, B.; Thaçi, D.; Warren, R.B.; Tyring, S.; Arikan, D.; Karunaratne, M.; Valdecantos, W.C. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Systematic review of the real‐world evidence of adalimumab safety in psoriasis registries. (28th August 2018) Authors: Strober, B.; Crowley, J.; Langley, R.G.; Gordon, K.; Menter, A.; Leonardi, C.; Arikan, D.; Valdecantos, W.C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 12(2018) Page Start: 2126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 阿达木单抗在斑块型银屑病成人患者中的长期安全性. (1st January 2019) Authors: Leonardi, C.; Papp, K.; Strober, B.; Thaçi, D.; Warren, R.B.; Tyring, S.; Arikan, D.; Karunaratne, M.; Valdecantos, W.C. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 阿达木单抗在斑块型银屑病成人患者中的长期安全性. (2nd January 2019) Authors: Leonardi, C.; Papp, K.; Strober, B.; Thaçi, D.; Warren, R.B.; Tyring, S.; Arikan, D.; Karunaratne, M.; Valdecantos, W.C. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗